111 SOUTH WACKER DRIVE,34TH FLOOR
CHICAGO , IL, 60606

Rank

Rank Universe
0 508

Summary

The fund seeks capital appreciation in the long term by investing in companies across any size outside the United States.

The sub-adviser’s investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in a diversified portfolio of non-U.S. securities.

More

Link

Directors

Jan 11, 2024
  • Scott M. Amero
  • Kathryn L. Quirk
  • Douglas J. Skinner
  • Ann M. Spruill
  • Donna J. Dean
  • Robert Kasdin
  • Charles F. McCain
  • Landis Zimmerman

Chief Compliance Officer

  • Diana R. Podgorny

Fund Manager(s)

  • Ryan Taliaferro
  • Brendan Bradley

Price

  • $ 12.8 ( -0.08 )
    Dec 30, 2024
    Last Close
  • Net Assets
  • $197.1M
    Apr 1, 2024
  • Holding
  • 452
    Sep 27, 2024
    More

  • 52-Week High/Low
  • $13.85 - $11.49
  • Turnover
  • 73%
  • Expense Ratio
  • 1.43%

Company Name

Holding

Roche Holding AG 3.59 %
Novo Nordisk A/S 3.48 %
ABB Ltd 2.62 %
UniCredit SpA 2.03 %
Wolters Kluwer NV 2 %
Industria de Diseno Textil SA 1.67 %
CaixaBank SA 1.64 %
Holcim AG 1.62 %
Check Point Software Technologies Ltd 1.58 %
Aristocrat Leisure Ltd 1.56 %
More 1.56 %

Advisor

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

0.31%

5 Year

20.3%

Best

11.72%

2020

Worst

-17.53%

2022

Alpha

HAONX S&P 500

Chart +